RecruitingInterventionalPhase 3Last updated Jan 10, 2025

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Overview

ClinicalTrials.gov ID: NCT06082063
Lead Sponsor: Steno Diabetes Center CopenhagenOTHER
Brief Summary: A prospective, randomised, open-labelled, multi-center study. The aim of the Steno 1 study is to test multifactorial intervention in individuals with type 1 diabetes at high risk of CVD with ambitious treatment targets. We will include 2000 participants. Follow-up is 5 years.
Study Type

Status

Overall Status: Recruiting
Start Date: Jul 1, 2024Actual
Primary Completion Date: Jul 1, 2029Estimated
Completion Date: Jul 1, 2029Estimated

Study Record Dates

First Submitted: May 16, 2023
First Submitted that Met QC Criteria: Oct 8, 2023
First Posted: Oct 13, 2023Actual
Last Update Submitted that Met QC Criteria: Jan 8, 2025
Last Update Posted: Jan 10, 2025Actual
Last Verified: Jan 2025

NCT07270172Recruiting

The MICRON Study - A Steno 1 Substudy

NCT06290544Unknown status

Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)

NCT06147232Not yet recruiting

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

NCT03315143Terminated

Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

NCT06435156Recruiting

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

NCT01730534Completed

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events